Skip to search formSkip to main contentSkip to account menu

panipenem

Known as: 1-Azabicyclo(3.2.0)hept-2-ene-2-carboxylic acid, 6-(1-hydroxyethyl)-3-((1-(1-iminoethyl)-3-pyrrolidinyl)thio)-7-oxo-, (5R-(3(S*),5alpha,6alpha(R*)))-, 6-(1-hydroxyethyl)-2-(1--acetimidoylpyrrolidin-3-ylthio)-1-carbapen-2-em-3-carboxylic acid 
A broad-spectrum parenteral carbapenem with activity against aerobic, anaerobic, gram-positive and gram-negative organisms including non-fermenters… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2017
Review
2017
Review
2011
Review
2011
ABSTRACT In this review, we summarize the current “state of the art” of carbapenem antibiotics and their role in our… 
Highly Cited
2004
Highly Cited
2004
ABSTRACT Immature renal function in neonates requires antibiotic dosage adjustment. Population pharmacokinetic studies were… 
Highly Cited
1999
Highly Cited
1999
Previously, a significant decrease in the trough plasma-concentration of valproic acid (VPA) owing to the concomitant… 
1998
1998
ABSTRACT There is evidence indicating that the carbapenem antibiotic panipenem decreases plasma concentrations of valproic acid… 
1998
1998
Serum concentrations of valproic acid (VPA) were reduced to 0% to 40% of the original levels by concomitant use with panipenem…